We offer patients emerging treatments for macular diseases.
Browse a list of current, upcoming and previous clinical trials conducted through the Clinical Research Unit.
Trial | Condition | Details |
---|---|---|
Constance | Wet AMD |
Ethics approval SVHM HREC 310/24 |
iSight iLumen | Dry AMD | Find out more - recruitment opening soon Ethics approval Bellberry 2024/ETH02730 |
ARCHER II | Dry AMD - Geographic Atrophy |
Ethics approval SVHM HREC/230/24 |
Brunello | Diabetic Macular Oedema |
Ethical approval SVHM HEC/168/24 |
Vantage | Non -proliferative Diabetic Retinopathy |
Ethical approval SVHM HREC 250/24 |
Vista | X-linked Retinitis Pigmentosa |
Ethical approval SVHM HREC: HREC 152/54 |
BenoBio | Wet AMD |
Ethical approval Bellberry HREC 2024/ETH01779 |
KIRIN DME | DME |
Ethical approval HREC/103584/SVHM-2023 |
PHOENIX | Dry AMD - Geographic Atrophy |
Ethical approval HREC/99641/SVHM-2023-378051 |
VIVID WHITE | Glaucoma |
Ethics approval HREC/102954/SVHM-2023-400792(v2) |
RADAR | Diabetic Eye Disease | Ethical approval HREC/13/SAC/92 |
MacTel Project | MacTel |
Ethical approval HREC/16/POWH/215 |
"I was so happy with the whole team's service and with how kind everyone was at every visit. It felt like family and 'home'. "
“I feel very honoured to be part of clinical trials helping find new medications for future patients...the research team provides a very high level of service to the patients involved.”
“My experience with the clinical trials team has been very good and I am very appreciative of the support that I received throughout my time with them.”
Hear more from our patients here.